The latest closing stock price for VistaGen Therapeutics as of January 17, 2025 is 2.92.
An investor who bought $1,000 worth of VistaGen Therapeutics stock at the IPO in 2016 would have $-976 today, roughly -1 times their original investment - a -34.02% compound annual growth rate over 9 years.
The all-time high VistaGen Therapeutics stock closing price was 132.30 on October 04, 2016.
The VistaGen Therapeutics 52-week high stock price is 5.74, which is 96.6% above the current share price.
The VistaGen Therapeutics 52-week low stock price is 2.22, which is 24% below the current share price.
The average VistaGen Therapeutics stock price for the last 52 weeks is 3.72.
An investor who bought $1,000 worth of VistaGen Therapeutics stock at the IPO in 2016 would have $-976 today, roughly -1 times their original investment - a -34.02% compound annual growth rate over 9 years.
The all-time high VistaGen Therapeutics stock closing price was 132.30 on October 04, 2016.
The VistaGen Therapeutics 52-week high stock price is 5.74, which is 96.6% above the current share price.
The VistaGen Therapeutics 52-week low stock price is 2.22, which is 24% below the current share price.
The average VistaGen Therapeutics stock price for the last 52 weeks is 3.72.